Purchase Order 36C26326P0294

On March 6, 2026, the Department of Veterans Affairs, Veterans Integrated Service Network 23 (Minneapolis, MN), awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) systems and related cardiovascular medical devices. The contract, with an ultimate completion date of March 9, 2026, carries no set-aside designation and represents a sole-source procurement reflecting Edwards Lifesciences' exclusive manufacturing capability for the specified cardiac technologies. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, specializes in the design and distribution of advanced cardiovascular devices including transcatheter heart valves and surgical implants critical to the VA's cardiac surgical programs.

This award is consistent with Edwards Lifesciences LLC's extensive portfolio of over 200 prime federal contract awards since 2025, the vast majority issued by the Department of Veterans Affairs across multiple VISNs. The company maintains two primary Indefinite Delivery Contracts with the VA totaling $7.45 million in ceiling value—a $6.5 million five-year IDV with VISN 21 for surgical implant consignment services and a $950,000 five-year IDV with VISN 15 for heart valves and cardiovascular devices. These framework agreements establish Edwards Lifesciences LLC as a primary supplier of specialized cardiac technologies essential to veteran patient outcomes, with individual purchase orders typically ranging from $32,500 to $102,000.